PRIVIA HEALTH GROUP, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.01 USD | -0.88% |
|
+1.01% | -21.84% |
| Apr. 22 | Citigroup Starts Privia Health Group With Buy Rating, $25 Price Target | MT |
| Mar. 19 | Canaccord Genuity Adjusts Privia Health Group Price Target to $37 From $41, Maintains Buy Rating | MT |
Chart calendar Privia Health Group, Inc.
f42105f2aab89ac98b6817.lSh6wI7FPTQdkUloGAI970q45n1EHBXn_4CbYvNQnos.pn07p8CPdX5f1SgSVXRRoQfJkkx1SlG4qeXOALwKr_HcEACB-Yt3XW2gLg~65d90c9eef09bca7f9ce5cf039565a9b
Upcoming events on Privia Health Group, Inc.
Past events on Privia Health Group, Inc.
| 2024-02-27 08:00 am | Q4 2023 Earnings Call |
| 2024-02-27 06:00 am | Q4 2023 Earnings Release |
| 2024-01-08 06:45 pm | JPMorgan Healthcare Conference |
| 2023-11-03 08:00 am | Q3 2023 Earnings Call |
| 2023-11-03 06:30 am | Q3 2023 Earnings Release |
| 2023-09-13 12:15 pm | Morgan Stanley Global Healthcare Conference |
| 2023-08-03 08:30 am | Q2 2023 Earnings Call |
| 2023-08-03 07:00 am | Q2 2023 Earnings Release |
| 2023-06-07 01:30 pm | Jefferies Global Healthcare Conference |
| 2023-06-06 09:00 am | William Blair Growth Stock Conference |
| 2023-05-24 11:00 am | Annual General Meeting |
| 2023-05-04 08:45 am | Q1 2023 Earnings Call |
| 2023-05-04 06:30 am | Q1 2023 Earnings Release |
| 2023-02-28 08:30 am | Q4 2022 Earnings Call |
| 2023-02-28 07:00 am | Q4 2022 Earnings Release |
| 2023-01-09 06:00 pm | JP Morgan Healthcare Conference |
| 2022-11-30 10:00 am | Piper Sandler Healthcare Conference |
| 2022-11-10 08:30 am | Q3 2022 Earnings Call |
| 2022-11-10 07:00 am | Q3 2022 Earnings Release |
| 2022-09-13 09:05 am | Baird Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 817 | 966 917 5.32% | 1 357 1 326 2.33% | 1 658 1 644 0.83% | 1 645 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 41,4 40,8 1.43% | 60,9 60,1 1.19% | 72,2 72,9 -0.98% | 87,5 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -217 -216 -0.8% | -19,1 -23,6 18.86% | 20,6 24,1 -14.37% | 30,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -219 -218 -0.41% | -18,6 -24,5 24.16% | 29,0 31,6 -8.21% | 39,1 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -188 -191 1.28% | -8,59 -26,3 67.38% | 23,1 25,8 -10.58% | 29,8 |
|
EPS USD | Released Forecast Spread | 0,33 | -1,83 -1,57 -16.68% | -0,08 -0,23 65.76% | 0,19 0,21 -7.86% | 0,24 |
| Announcement Date | 17/03/21 | 22/03/22 | 28/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 275 227 21.54% | 314 295 6.52% | 336 315 6.58% | 343 319 7.56% | 364 333 9.29% | 386 378 2.11% | 413 394 4.96% | 417 411 1.61% | 441 427 3.25% | 394 | 407 | 413 | 430 | 456 |
|
EBITDA Million USD | Released Forecast Spread | 7,53 6,47 16.4% | 14,8 10,3 44.16% | 15,5 11,9 30.81% | 15,7 14,7 6.64% | 14,3 13,8 3.14% | 16,9 15,6 7.88% | 19,3 18,0 7.05% | 18,8 18,8 0.01% | 17,3 18,0 -4.14% | 19,7 | 22,0 | 23,2 | 22,4 | 23,6 |
|
EBIT Million USD | Released Forecast Spread | -19,3 -14,3 -34.97% | -11,5 -10,1 -14.13% | -5,25 -7,65 31.4% | -4,57 0,34 -1453.74% | 2,25 -2,19 202.59% | 6,71 1,69 296.13% | 6,98 7,89 -11.58% | 5,54 5,89 -6.02% | 1,42 4,85 -70.72% | 5,63 | 7,77 | 8,94 | 8,20 | 10,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -19,5 -18,9 -3.34% | -11,8 -11,3 -4.63% | -5,91 -5,38 -9.92% | -4,29 1,63 -363.43% | 3,40 -3,10 209.87% | 8,53 2,33 265.24% | 7,80 6,53 19.33% | 8,43 5,89 43.19% | 4,27 7,25 -41.13% | 7,48 | 9,78 | 11,0 | 10,6 | 11,8 |
|
Net income Million USD | Released Forecast Spread | -12,0 -13,5 11.16% | -17,5 -7,17 -144.11% | -10,5 -4,35 -140.73% | 1,62 0,79 105.26% | 17,8 -0,33 5412.77% | 7,32 1,66 342.35% | 7,27 6,18 17.61% | 5,64 5,94 -5.04% | 2,84 5,69 -50.11% | 6,06 | 7,71 | 8,30 | 7,78 | 8,84 |
|
EPS USD | Released Forecast Spread | -0,11 -0,11 1.61% | -0,16 -0,05 -215.15% | -0,10 -0,04 -150% | 0,01 0,00 147.52% | 0,14 -0,01 2746.5% | 0,06 0,02 234.63% | 0,06 0,06 -5.65% | 0,05 0,05 -3.92% | 0,02 0,05 -55.99% | 0,05 | 0,06 | 0,07 | 0,07 | 0,07 |
| Announcement Date | 22/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 28/02/23 | 04/05/23 | 03/08/23 | 03/11/23 | 27/02/24 | - | - | - | - | - |
More events
Past sector events for Privia Health Group, Inc.
| Today | ACCOLADE, INC.: Q4 2024 Earnings Release |
| Today | LABORATORY CORPORATION OF AMERICA HOLDINGS: Q1 2024 Earnings Release |
| Today | BUMRUNGRAD HOSPITAL: Q1 2024 Earnings Release |
| Today | MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-24 04:16 pm | UNIVERSAL HEALTH SERVICES, INC.: Q1 2024 Earnings Release |
| 2024-04-24 04:15 pm | CHEMED CORPORATION: Q1 2024 Earnings Release |
| 2024-04-24 02:00 am | ATTENDO AB: Q1 2024 Earnings Release |
| 2024-04-24 01:15 am | EUROFINS SCIENTIFIC SE: Q1 2024 Sales and Revenue Release - Trading Update |
| 2024-04-23 07:00 am | OPTION CARE HEALTH, INC.: Q1 2024 Earnings Release |
| 2024-04-23 06:45 am | QUEST DIAGNOSTICS INCORPORATED: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PRVA Stock
- Calendar Privia Health Group, Inc.
